Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response

Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response

Background: Although the standard of care is to perform surgery of primary breast cancer (BC) after neoadjuvant chemotherapy (NAC), for certain patients achieving clinical complete response (cCR) and pathologic complete response (pCR), omission of surgical treatment may be an option. Levels of circu...

Full description

Bibliographic Details
Main Authors: Nikaoly Ciriaco, Esther Zamora, Santiago Escrivá-de-Romaní, Ignacio Miranda Gómez, José Jiménez Flores, Cristina Saura, Hillary Sloane, Anna Starus, Johannes Fredebohm, Lucy Georgieva, Graham Speight, Frederick Jones, Santiago Ramón y Cajal, Martín Espinosa-Bravo, Vicente Peg
Format: Article
Language:English
Published: SAGE Publishing 2022-11-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359221139601

Internet

https://doi.org/10.1177/17588359221139601

Similar Items